Rick Wanstall

VP, Finance and Operations, Rein Therapeutics, Inc.

Companies

Oncorus, Inc.Chief financial officer May 12, 2022 to May 25, 2022¹
Rein Therapeutics, Inc.VP, Finance and Operations Apr 3, 2019 to Mar 30, 2022²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROncorus, Inc., Chief financial officer
2
SEC EDGARRein Therapeutics, Inc., VP, Finance and Operations